Literature DB >> 8432898

Mast cell numbers in melanocytic naevi and cutaneous neurofibromas.

N J Carr1, A Y Warren.   

Abstract

This study aimed to determine the diagnostic utility of mast cell densities in distinguishing neurotised ("neural") melanocytic naevi from neurofibromas. Three groups of lesions were studied: neurofibromas, neural naevi, and naevi showing no neural change (control naevi). A Giemsa stain was used to demonstrate mast cells. The median mast cell density in the neurotised naevus group was significantly higher (p < 0.005) than that of both the neurofibroma and control naevus groups, but the distributions of the individual density counts overlapped considerably. The sensitivity and specificity of the mast cell density as a potential discriminator between neurotised naevi and neurofibromas, determined in relation to the optimal discrimination value obtained using Bayes' minimum cost decision rule, were low. It is concluded that mast cell density on its own is of little use as a classification tool but could be of value in the context of a multivariate decision rule.

Entities:  

Mesh:

Year:  1993        PMID: 8432898      PMCID: PMC501123          DOI: 10.1136/jcp.46.1.86

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

1.  Nerve fibers, a neglected component of intradermal cellular nevi.

Authors:  W B SHELLEY; R P ARTHUR
Journal:  J Invest Dermatol       Date:  1960-01       Impact factor: 8.551

2.  Age-related changes in melanocytic naevi.

Authors:  J C Maize; G Foster
Journal:  Clin Exp Dermatol       Date:  1979-03       Impact factor: 3.470

3.  The possible role of mast cells in pigmented nevi.

Authors:  L Szekeres
Journal:  Arch Dermatol Forsch       Date:  1974

4.  Mast cell and lymphoreticular infiltrates in neurofibromas. Comparison with nerve sheath tumors.

Authors:  M D Johnson; J Kamso-Pratt; C F Federspiel; W O Whetsell
Journal:  Arch Pathol Lab Med       Date:  1989-11       Impact factor: 5.534

5.  Mast cells in benign nerve sheath tumours.

Authors:  P Isaacson
Journal:  J Pathol       Date:  1976-08       Impact factor: 7.996

6.  A survey of cutaneous neural lesions for the presence of myelin basic protein. An immunohistochemical study.

Authors:  N S Penneys; R Mogollon; A Kowalczyk; M Nadji; K Adachi
Journal:  Arch Dermatol       Date:  1984-02
  6 in total
  5 in total

Review 1.  A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.

Authors:  Nancy Ratner; Shyra J Miller
Journal:  Nat Rev Cancer       Date:  2015-04-16       Impact factor: 60.716

2.  Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: identification and enumeration.

Authors:  A Orfao; L Escribano; J Villarrubia; J L Velasco; C Cerveró; J Ciudad; J L Navarro; J F San Miguel
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

3.  Perinatal epidermal growth factor receptor blockade prevents peripheral nerve disruption in a mouse model reminiscent of benign world health organization grade I neurofibroma.

Authors:  Jianqiang Wu; Jason T Crimmins; Kelly R Monk; Jon P Williams; Maureen E Fitzgerald; Susan Tedesco; Nancy Ratner
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

Review 4.  It takes two to tango: mast cell and Schwann cell interactions in neurofibromas.

Authors:  David H Viskochil
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

5.  Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.

Authors:  Jineta Banerjee; Robert J Allaway; Jaclyn N Taroni; Aaron Baker; Xiaochun Zhang; Chang In Moon; Christine A Pratilas; Jaishri O Blakeley; Justin Guinney; Angela Hirbe; Casey S Greene; Sara Jc Gosline
Journal:  Genes (Basel)       Date:  2020-02-21       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.